Decipher Urologic Cancers Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
92
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$600M
Decipher Urologic Cancers General Information
Description
Developer of genomic tests designed to improve cancer patient care and outcomes. The company's platform is a clinically annotated genomic expression database for urological cancers, enabling the medical community and cancer patients to optimally access an assessment of tumor aggressiveness based on their unique genomic profile.
Contact Information
Website
www.decipherbio.com(Operating Subsidiary)
Corporate Office
- 10355 Science Center Drive
- Suite 240
- San Diego, CA 92121
- United States
Corporate Office
- 10355 Science Center Drive
- Suite 240
- San Diego, CA 92121
- United States
Decipher Urologic Cancers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Merger/Acquisition | 12-Mar-2021 | $600M | Completed | Generating Revenue | ||
| 13. IPO | 19-Jan-2021 | Cancelled | Generating Revenue | |||
| 12. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 11. Later Stage VC | 26-May-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 10-Apr-2019 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series E) | 05-Oct-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 27-Jun-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 09-Mar-2016 | $33.2M | $63.8M | Completed | Generating Revenue | |
| 5. Debt - General | 28-Sep-2015 | $30M | $30.5M | Completed | Generating Revenue |
Decipher Urologic Cancers Comparisons
Industry
Financing
Details
Decipher Urologic Cancers Competitors (29)
One of Decipher Urologic Cancers’s 29 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| StageZero Life Sciences | Corporation | Richmond Hill, Canada | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Boreal Genomics | Formerly VC-backed | Vancouver, Canada | ||||
| Nucleix | Venture Capital-Backed | Rehovot, Israel |
Decipher Urologic Cancers Signals
Decipher Urologic Cancers Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Albany Capital (Australia) | Venture Capital | Minority | ||
| Baird Capital | PE/Buyout | Minority | ||
| CD-Venture | Venture Capital | Minority | ||
| Calibrium (Zurich) | Family Office | Minority | ||
| EMBL Ventures | Venture Capital | Minority |
Decipher Urologic Cancers FAQs
-
When was Decipher Urologic Cancers founded?
Decipher Urologic Cancers was founded in 2008.
-
Where is Decipher Urologic Cancers headquartered?
Decipher Urologic Cancers is headquartered in San Diego, CA.
-
What is the size of Decipher Urologic Cancers?
Decipher Urologic Cancers has 92 total employees.
-
What industry is Decipher Urologic Cancers in?
Decipher Urologic Cancers’s primary industry is Diagnostic Equipment.
-
Is Decipher Urologic Cancers a private or public company?
Decipher Urologic Cancers is a Private company.
-
What is the current valuation of Decipher Urologic Cancers?
The current valuation of Decipher Urologic Cancers is .
-
What is Decipher Urologic Cancers’s current revenue?
The current revenue for Decipher Urologic Cancers is .
-
How much funding has Decipher Urologic Cancers raised over time?
Decipher Urologic Cancers has raised $106M.
-
Who are Decipher Urologic Cancers’s investors?
Albany Capital (Australia), Baird Capital, CD-Venture, Calibrium (Zurich), and EMBL Ventures are 5 of 12 investors who have invested in Decipher Urologic Cancers.
-
Who are Decipher Urologic Cancers’s competitors?
CirculoGene, StageZero Life Sciences, Foundation Medicine, Boreal Genomics, and Nucleix are some of the 29 competitors of Decipher Urologic Cancers.
-
When was Decipher Urologic Cancers acquired?
Decipher Urologic Cancers was acquired on 12-Mar-2021.
-
Who acquired Decipher Urologic Cancers?
Decipher Urologic Cancers was acquired by Veracyte.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process